Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | CES2 | O00748 | 2/20 | 0.59 |
| ▸ | CES1 | P23141 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3658372 | 1.00 | TDP1 (0.61) | TDP1L3MBTL1LMNACES2CES1 | |
| Hydrochloric Acid SCHEMBL9150834 | 0.98 | TDP1 (0.59) | TDP1L3MBTL1LMNACES2CES1 | |
| Chlorobenzene SCHEMBL27608976 | 0.90 | TDP1 (0.52) | TDP1L3MBTL1LMNACES2CES1 | |
| SCHEMBL11205532 | 0.89 | TDP1 (0.54) | TDP1L3MBTL1LMNACES2CES1 | |
| SCHEMBL8805626 | 0.86 | NPC1 (0.50) | TDP1L3MBTL1LMNACES2CES1 | |
| SCHEMBL6205111 | 0.86 | CES2 (0.52) | TDP1L3MBTL1LMNACES2CES1 | |
| Hydrochloric Acid SCHEMBL4015538 | 0.85 | CES2 (0.50) | TDP1L3MBTL1LMNACES2CES1 | |
| Hydrochloric Acid SCHEMBL4329394 | 0.85 | NPC1 (0.49) | TDP1L3MBTL1LMNACES2CES1 | |
| SCHEMBL3320904 | 0.82 | MEN1 (0.54) | TDP1L3MBTL1LMNACES2CES1 | |
| SCHEMBL6203223 | 0.82 | ALDH1A1 (0.55) | TDP1LMNAALDH1A1CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108003699-B | Protective printing ink for glass acid etching process and preparation method and application thereof | 广州亦盛环保科技有限公司 | 2021-08-06 | — | — | CN | claimed |
| CN-115926534-A | UV curable inkjet ink composition | 韩国太阳油墨股份公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-114787293-B | Surface protective agent composition and covered electric wire with terminal | 株式会社自动网络技术研究所 | 2023-04-04 | — | — | CN | disclosed |
| CN-112940560-B | Photosensitive solder resist ink composition, use thereof and circuit board containing same | 深圳市容大感光科技股份有限公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-115298614-A | Photosensitive material, transfer film, method for manufacturing circuit wiring, method for manufacturing touch panel, and pattern forming method | 富士胶片株式会社 | 2022-11-04 | — | — | CN | disclosed |
| CN-115280239-A | Transfer film, photosensitive material, pattern forming method, method for manufacturing circuit board, and method for manufacturing touch panel | 富士胶片株式会社 | 2022-11-01 | — | — | CN | disclosed |
| CN-115197596-A | High-flatness hardened film for carrier plate and preparation method thereof | 广东硕成科技股份有限公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-114787293-A | Surface protective agent composition and covered electric wire with terminal | 株式会社自动网络技术研究所 | 2022-07-22 | — | — | CN | disclosed |
| CN-109721566-B | Preparation method of 1- (4-morpholine phenyl) -1-butanone | 天津久日新材料股份有限公司 | 2022-03-22 | — | — | CN | disclosed |
| US-11129790-B2 | Chemo-enzymatic site-specific modification of peptides and proteins to form cleavable conjugates | NORTHEASTERN UNIVERSITY (US) | 2021-09-28 | — | — | US | disclosed |
| EP-0005156-B1 | 4,5-DIARYL-2-(SUBSTITUTED-THIO)-PYRROLES AND THEIR CORRESPONDING SULFOXIDES AND SULFONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-09-22 | — | — | EP | disclosed |
| US-4335136-A | Anti-inflammatory 4,5-diaryl-α-(polyfluoroalkyl)-1H-pyrrole-2-methanamines | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-06-15 | — | — | US | disclosed |
| EP-0038997-A1 | Anti-inflammatory 4,5-diaryl-alpha, alpha-bis(polyfluoroalkyl)-1H-pyrrole-2-methane thiols, processes for their preparation and pharmaceutical compositions containing them | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-11-04 | — | — | EP | disclosed |
| EP-0038536-A1 | Antiinflammatory 4,5-diaryl-alpha-(polyfluoroalkyl)-1H-pyrrole-2-methanamines | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-10-28 | — | — | EP | disclosed |
| EP-0034798-A2 | Antiinflammatory 4,5-diaryl-2-(substituted-thio)pyrroles and their corresponding sulfoxides and sulfones | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-09-02 | — | — | EP | disclosed |
| US-4267190-A | AND METHOD OF ADMINISTERING TO MAMMALS FOR TREATMENT OF ARTHRITIS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-05-12 | — | — | US | disclosed |
| US-4267184-A | USEFUL FOR TREATING ARTHRITIS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-05-12 | — | — | US | disclosed |
| EP-0025884-A1 | 4,5-Diaryl-alpha-polyfluoroalkyl-1H-pyrrole-2-methanols and 1-(4,5-diaryl-1H-pyrrol-2-yl)-polyfluoroalkanones, processes for preparing them and pharmaceutical compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-04-01 | — | — | EP | disclosed |
| EP-0005156-A1 | 4,5-diaryl-2-(substituted-thio)-pyrroles and their corresponding sulfoxides and sulfones, process for their preparation and pharmaceutical compositions containing them | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1979-11-14 | — | — | EP | disclosed |
| US-4020082-A | ANTIPHLOGISTIC, ANALGESIC, ANTIAGGREGANT, LOCAL ANESTHETIC | MARCHETTI ENZO | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11129790-B2 | Chemo-enzymatic site-specific modification of peptides and proteins to form cleavable conjugates | GLUL, QPCT, DNPEP | TDP1 1599/4885L3MBTL1 2682/4885LMNA 4624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.